Skip to main content
Caplight Logo









Cellaven

Cellaven

Private
FranceHealthcare & Life Scienceshttps://cellaven.com

Last Round

Seed

Jul 3, 2024

Total Funding Raised

$3.04M

Company Overview

Cellaven operates in Healthcare & Life Sciences and is based in France. Its latest recorded funding round was a Seed round in July 2024.

Cellaven is a laboratory equipment company that manufactures an automated cell culture device intended to improve the efficiency and reproducibility of cell culture research.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cellaven Comparables

Compare Cellaven with similar companies based on industry and business-model similarity.

Cellaven comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
mo:re
82%
Cell X Technologies
73%
FORMULATRIX
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cellaven Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 3, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Marc Barsoum

Chief Revenue Officer (CRO) & Co-Founder

Founding Team

Julien Maruotti

Co-founder & CEO

Founding Team

For institutional investors. Book with your work email.

Cellaven Investors

Notable investors and investment history

Cellaven investors
InvestorRounds
Finovam GestionSeed
BpifranceSeed
INSEAD AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 3, 2024

    $3M round led by Bpifrance and Finovam

Book a demo to see all signals

For institutional investors. Book with your work email.

Cellaven Filings

Explore SEC and related filing metadata, where available.

Cellaven filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cellaven's valuation, stock price, and market status.

Is Cellaven a public or private company?

Cellaven is a private company.

What is the current stock price of Cellaven?

Cellaven is a private company, so its shares have no public market price. Caplight tracks Cellaven's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cellaven worth (valuation)?

Valuation information for Cellaven is not publicly available.

Can I buy Cellaven stock?

Cellaven shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cellaven's last funding round?

Cellaven's most recent funding round was Seed on July 3, 2024.

Who are the main investors in Cellaven?

Key investors in Cellaven include Finovam Gestion, Bpifrance.

Will Cellaven IPO soon?

No public IPO plans have been announced for Cellaven.

How can I track Cellaven secondary market activity?

Caplight tracks bids, offers, and trades in Cellaven's shares on secondary markets.

Firmographic Details

HeadquartersFrance
Employee Range7
Year Founded2022
Last FundingJul 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?